This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Christoph Rader
Professor, Department of Immunology and Microbiology at The Scripps Research Institute


Christoph Rader studied biochemistry in Germany and Switzerland where he received his PhD from the University of Zurich in 1995. Following postdoctoral training at The Scripps Research Institute (TSRI) in La Jolla, CA, he was appointed Assistant Professor at TSRI in 1999. In 2003, he was recruited as Senior Scientist to the National Cancer Institute, National Institutes of Health in Bethesda, MD. He rejoined TSRI in Jupiter, FL as Associate Professor with Tenure in 2012 and was promoted to Professor in 2019. In 2018, he was appointed as Associate Dean of the Skaggs Graduate School of Chemical and Biological Studies at TSRI, a top ten PhD program in chemistry, biochemistry, and biology. His laboratory has focused on antibody drug and target discovery for cancer therapy including the utilization of phage display for antibody generation, affinity maturation, and humanization, and for antigen discovery. Several antibodies developed in the Rader laboratory have reached preclinical and clinical investigations. Christoph Rader has authored >100 peer-reviewed journal articles and is named inventor on >25 issued and pending patent families.

Agenda Sessions

  • Antibody Binding Sites as Therapeutics: scFv, VHH, VNAR and Beyond: A Tribute Session to Jim Huston's Invaluable Contributions Over his 45+ Year Career

  • scFv Meets Fab: New Switchable CAR-Ts

    On Demand

Speakers at this event